3

FORM 3 SUBMISSION

Company: Viridian Therapeutics, Inc.\DE
Filed: October 4, 2021
Period of Report: October 1, 2021
Accession Number: 0000899243-21-038873

View Document ↗ View on SEC.gov ↗